Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study-Reference-Cited by-同舟云学术

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

Published:2015-03-11 Issue:6 Volume:54 Page:939-943
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Harjama Liisa,Kuitunen Hanne,Turpeenniemi-Hujanen Taina,Haapasaari Kirsi Maria,Leppä Sirpa,Mannisto Susanna,Karjalainen-Lindsberg Marja-Liisa,Lehtinen Tuula,Eray Mine,Vornanen Martine,Haapasalo Hannu,Soini Ylermi,Jantunen Esa,Nousiainen Tapio,Vasala Kaija,Kuittinen Outi

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2014.990110

Reference15 articles.

1. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003

2. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

3. Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

4. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma

5. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the management of primary central nervous system lymphoma;Critical Reviews in Oncology/Hematology;2023-08

2. Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma;British Journal of Haematology;2023-07-31

3. Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study;Cancers;2023-02-20

4. Analysis of Key Factors Associated with Response to Salvage High-Dose Methotrexate Rechallenge in Primary Central Nervous System Lymphoma with First Relapse;Current Oncology;2022-09-17

5. Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis;BMC Cancer;2022-03-03